Trial intelligence / Profile preview

Bioequivalence of ESTAPRAM 20 vs Lexapro 20 mg in healthy Thai volunteers (fasting)

TCTR20210503003Phase 1Not yet recruiting

Sponsor
International Bio Service
Start
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of escitalopram (2 arms), sponsored by International Bio Service. Planned start Aug 2021; status: not yet recruiting.

02

Drugs

escitalopram

Beyond the preview

Go deeper on TCTR20210503003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210503003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call